In ₹ Crore except Per Share Latest Annual	AKUMS FY26	ALIVUS FY24	AGARWALEYE FY26	ADVENZYMES FY26	Peer Average
Valuation — at last close
P/E	44.45×	—	116.08×	◆ 17.52×	66.80× -33%
P/B	3.42×	—	7.64×	◆ 1.81×	4.73× -28%
EV/EBITDA	18.69×	—	27.13×	◆ 10.16×	18.65× 0%
Market Cap	₹11,346 Cr	—	₹15,482 Cr	₹2,956 Cr	₹9,219 Cr +23%
Growth
Revenue CAGR 3Y	—	—	—	11.32%	11.32%
Revenue CAGR 5Y	—	—	—	8.24%	8.24%
Net Income CAGR 3Y	—	—	—	18.68%	18.68%
Revenue YoY (latest Q)	13.93%	—	◆ 25.97%	2.08%	14.02% -1%
Net Income YoY (latest Q)	◆ 56.11%	—	44.56%	-4.58%	19.99% +181%
Profitability
EBITDA Margin	11.98%	29.53%	27.38%	◆ 30.72%	29.21% -59%
Net Income Margin	5.88%	20.62%	8.08%	◆ 23.28%	17.33% -66%
Return on Common Equity	8.02%	◆ 21.07%	6.84%	11.05%	12.99% -38%
Return on Capital Employed	9.71%	◆ 26.94%	8.79%	11.61%	15.78% -38%
Return on Assets	5.36%	◆ 16.96%	4.42%	10.03%	10.47% -49%
Credit & Quality
Total Debt/Equity	0.02×	—	0.07×	◆ 0.01×	0.04× -50%
Interest Coverage	3.91×	◆ 401.55×	3.24×	71.91×	158.90× -98%
Scale — latest FY
Revenue / Total Income	₹4,359 Cr	₹2,283 Cr	₹2,080 Cr	₹746 Cr	₹1,703 Cr +156%
Net Income	₹256 Cr	₹471 Cr	₹168 Cr	₹174 Cr	₹271 Cr -5%
Total Assets	₹5,447 Cr	₹2,850 Cr	₹3,942 Cr	₹1,839 Cr	₹2,877 Cr +89%
EPS	₹16.67	—	₹4.21	₹15.08	₹9.65 +73%
Book Value per Share	₹216.41	—	₹63.93	₹145.81	₹104.87 +106%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.